The chronic and progressive inflammatory disease bronchiectasis is characterised by permanent bronchi dilation and by ...

Shares in Insmed have rocketed after the biotech reported positive results in a highly-anticipated clinical trial of brensocatib in the respiratory disorder bronchiectasis. The phase 3 trial ...

The lungs were harvested from a brain-dead patient in Thanjavur and brought to Rela Hospital in a record 2 hours and 20 ...

Insmed Inc. (INSM) said it presented positive late-breaking subgroup data from the Phase 3 ASPEN study, a global, randomized, ...

Rela Hospital completed a bilateral lung transplant on Shanmugapriya, an 18-year-old girl from Tuticorin, giving her a new ...

Considering taking supplements to treat bronchiectasis? Below is a list of common natural remedies used to treat or reduce the symptoms of bronchiectasis. Follow the links to read common uses ...

If poorly controlled, asthma can cause structural changes to the lungs, leading to more frequent and severe asthma attacks ...

Most pediatricians are aware of the more common causes of chronic cough, but sometimes unexpected cases come along that ...

Brensocatib, if approved, would be the first treatment for bronchiectasis and the first dipeptidyl peptidase 1 (DPP1) inhibitor, a new mechanism of action aimed at addressing a range of neutrophil ...

University of California San Diego and University of California Berkeley researchers have been awarded up to $7 million from ...

Electromed specializes in HFCWO therapy with its SmartVest System, targeting respiratory diseases. Find out my recommendation ...

The RespiriNTM project has received funding from the Innovative Health Initiative 2 Joint Undertaking (JU) under grant agreement No 853932. This Joined Undertaking receives support from the European ...